Fortress Biotech, Inc. (FBIO) Ownership

NASDAQ: FBIOTop holders, insider trades and short interest.

FBIO ownership summary

as of October 18, 2026
Institutions
31.2%
of shares outstanding
Insiders
23.90%
of shares outstanding
Shares outstanding
33.4M
Float
21.4M
shares available to trade
Short interest
19.00%
4.9M shares short
Days to cover
17.93
short interest down 4.1% vs prior month
  • Institutions 31.22%
  • Insiders 23.90%
  • Other investors 44.88%

FBIO top institutional holders

20 largest
Fortress Biotech, Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1Vanguard Capital Management, LLC3.11%1.0M$1.9M+71,173 (+7.4%)June 30, 2026
2Opaleye Management Inc2.67%890K$1.7M−152,000 (−14.6%)June 30, 2026
3Mackenzie Investments1.67%556K$1.0M+555,676 (0.0%)June 30, 2026
4GSA Capital Partners LLP1.37%458K$857,343+204,338 (+80.4%)June 30, 2026
5Shikiar Asset Management Inc0.92%305K$571,227—June 30, 2026
6Geode Capital Management, LLC0.90%301K$561,974+10,266 (+3.5%)June 30, 2026
7BlackRock Inc0.67%225K$420,342+27,697 (+14.1%)June 30, 2026
8Two Sigma Investments LLC0.64%214K$399,780+16,961 (+8.6%)June 30, 2026
9Bridgeway Capital Management, LLC0.53%177K$331,678−5,000 (−2.7%)June 30, 2026
10Vanguard Fiduciary Trust Co0.50%166K$311,114+23,836 (+16.7%)June 30, 2026
11HB Wealth Management, LLC0.35%117K$218,182−3,500 (−2.9%)June 30, 2026
12Kestra Advisory Services, LLC0.35%116K$217,359−13,566 (−10.5%)June 30, 2026
13Acadian Asset Management LLC0.32%107K$200,657+66,853 (+165.3%)June 30, 2026
14State Street Corp0.30%102K$189,994—June 30, 2026
15The Goldman Sachs Group Inc0.29%96K$180,189+96,358 (0.0%)June 30, 2026
16Renaissance Technologies Corp0.26%86K$161,549−13,200 (−13.3%)June 30, 2026
17Citadel Advisors Llc0.23%77K$144,112−103,224 (−57.3%)June 30, 2026
18Integrated Quantitative Investments LLC0.21%69K$128,454+68,692 (0.0%)June 30, 2026
19Panagora Asset Management Inc0.20%66K$123,467+9,357 (+16.5%)June 30, 2026
20Northern Trust Corp0.19%64K$118,992−166,421 (−72.3%)June 30, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 11 holders added 1.2M shares and 7 cut 457K.

FBIO top mutual fund and ETF holders

18 largest
Fortress Biotech, Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1Vanguard MStar Total Stk Mkt Idx Invest2.09%698K$1.3M—August 31, 2026
2Bridgeway Ultra-Small Company0.46%152K$284,928−30,000 (−16.5%)June 30, 2026
3Fidelity Extended Market Index0.43%142K$266,322−765 (−0.5%)August 31, 2026
4Mackenzie GQE US Small Cap F80.41%137K$255,696+2,000 (+1.5%)July 31, 2026
5iShares Micro-Cap ETF0.25%84K$157,235−580 (−0.7%)September 30, 2026
6Fidelity Total Market Index0.15%49K$92,228—August 31, 2026
7Fidelity Series Total Market Index0.12%41K$77,010+5,308 (+14.8%)August 31, 2026
8EA Bridgeway Omni Small-Cap Value ETF0.07%25K$46,750—September 30, 2026
9Fidelity Nasdaq Composite Index0.06%19K$34,688—August 31, 2026
10LL GLOBAL SMALL-MID CAP GRO 75/100 (FF)0.06%18K$34,350+18,369 (0.0%)June 30, 2026
11Vanguard MStar Inst Ttl StkMktIdxInstlPl0.05%18K$33,755—August 31, 2026
12Vanguard U.S. Eq Idx £ Acc0.04%13K$23,521—August 31, 2026
13Vanguard Balanced Index Inv0.03%10K$19,177—August 31, 2026
14IG Mackenzie GQE U.S. Sm Md Cap Eq C NL0.02%7,560$14,137−32,727 (−81.2%)July 31, 2026
15Nomura Healthcare Fund Class I0.02%6,666$12,465—August 31, 2026
161290 VT Micro Cap K0.02%5,933$11,095—August 31, 2026
17Avantis US Small Cap Equity ETF0.01%2,971$5,556—September 30, 2026
18GW GBL SM-MID CAP GROW 100/100 DSC (EGB)0.01%2,841$5,313+2,841 (0.0%)June 30, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

FBIO insider transactions

latest 12
Fortress Biotech, Inc. insider transactions
DateNameTransactionPriceSharesValue
2024-09-23Lindsay A Md RosenwaldBuy$1.84763,359$1.4M
2024-07-11Lindsay A Md RosenwaldBuy$7.485,000$37,400
2024-07-10David JinBuy$7.50500$3,750
2024-07-08Lindsay A Md RosenwaldBuy$7.355,000$36,750
2024-06-28Lindsay A Md RosenwaldBuy$1.6420,000$32,800
2024-05-20Dov KleinSell$1.8910,000$18,900
2024-05-16Lindsay A Md RosenwaldBuy$1.7610,000$17,600
2024-01-05Lindsay A Md RosenwaldBuy$2.3850,000$119,000
2023-11-14Lindsay A Md RosenwaldBuy$1.701,567,515$2.7M
2023-11-14Michael S WeissBuy$1.70147,058$249,999
2023-09-26Lindsay A Md RosenwaldBuy$4.206,666$27,997
2023-08-17Lindsay A Md RosenwaldBuy$176.25666$117,382

Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.

FBIO shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns FBIO

Institutional investors own 31.2% of Fortress Biotech's shares and insiders 23.90%. The largest holder is Vanguard Capital Management, LLC with 3.11% of the shares (1.0M), as of June 30, 2026. Among the top 20 institutions, 11 added shares and 7 reduced their stake in the latest filings. Short interest is 19.00% of the float, or 17.93 days of average trading volume. The share count rose 1,336.0% since 2014.

Related: FBIO analyst forecast, FBIO key metrics. See the FBIO stock overview for the latest quote and news.

FBIO ownership FAQ

Who owns the most Fortress Biotech stock?

The largest shareholders of Fortress Biotech are Vanguard Capital Management, LLC (3.11%), Opaleye Management Inc (2.67%), Mackenzie Investments (1.67%), GSA Capital Partners LLP (1.37%), Shikiar Asset Management Inc (0.92%).

What percentage of Fortress Biotech is owned by institutions?

Institutions hold 31.2% of Fortress Biotech's shares outstanding; insiders hold 23.90%.

Which funds own Fortress Biotech?

The largest fund holders of Fortress Biotech are Vanguard MStar Total Stk Mkt Idx Invest (2.09%), Bridgeway Ultra-Small Company (0.46%), Fidelity Extended Market Index (0.43%), Mackenzie GQE US Small Cap F8 (0.41%), iShares Micro-Cap ETF (0.25%).

What is Fortress Biotech's short interest?

4.9M shares of Fortress Biotech were sold short, 19.00% of the float; at the average daily volume it would take 17.93 days to cover.

Are insiders buying or selling Fortress Biotech?

Of the latest 12 reported insider transactions in Fortress Biotech (since August 17, 2023), 11 were purchases and 1 were sales.

How many shares of Fortress Biotech are outstanding?

Fortress Biotech has 33.4M shares outstanding, of which 21.4M are in the public float.

Biotechnology: ownership